Category Specific RSS

medtech

Artrya seeking to improve its chances of getting FDA approval for AI heart disease screener

“Coronary Artery Disease. We see you.” Quite literally, healthcare company Artrya (ASX: AYA) sees your heart disease through its artificial…

3 years ago

Optiscan to expands distribution throughout China for tumour detection microscope

With increasing health awareness across China, medtech company Optiscan (ASX: OIL) is set to increase the exposure of their in…

3 years ago

Lumos Diagnostics partners with Apatek to create rare disorder test for newborns

Phenylketonuria. Most people won't know what it is, let alone how to say it, let alone spell it. But for…

3 years ago

Oventus bites the dust as sleep apnea mouthguards fall into slumber with administrators called in

Despite their claims of being able to improve millions of lives by providing better sleep at night using their bite…

3 years ago

Knosys secures deal to provide back of house knowledge management for government health service

If you’ve ever wanted to determine the cause of that ache, pain, cough or sniffle sans doctor, you’ve likely found…

3 years ago

US-based heart centre to trial Artrya’s software for heart disease diagnosis

Coronary heart disease is the most prevalent type of heart disease and the leading single cause of death in Australia,…

3 years ago